CoChat

MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment

Puri, Basant K., Bydder, Graeme M., Counsell, Serena J., Corridan, Bryan J., Richardson, Alexandra J., Hajnal, Joseph V., Appel, Caroline, McKee, Heather M., Vaddadi, Krishna S., Horrobin, David F. · 2002 · Neuroreport
Cited by 100

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

A 6-month randomized, placebo-controlled pilot study of the ethyl-ester of eicosapentaenoic acid (ethyl-EPA) was carried out in seven in-patients with advanced (stage III) Huntington's disease (three on ethyl-EPA, four on placebo; no significant difference in age or sex between the groups). After 6 months all the patients treated with ethyl-EPA improved on the orofacial component of the Unified Huntington's Disease Rating Scale while all the patients on placebo deteriorated on this scale (p < 0.03). Following subvoxel registration of follow-up 3D MRI brain scans with baseline scans, subtraction images showed that while the placebo was associated with progressive cerebral atrophy, the ethyl-EPA was associated with a reverse process. We conclude that treatment with ethyl-EPA is associated with beneficial motor and MRI changes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00001756-200201210-00029

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 100

Metadata

Authors
Puri, B. K., Bydder, G. M., Counsell, S. J., Corridan, B. J., Richardson, A. J., Hajnal, J. V., Appel, C., McKee, H. M., Vaddadi, K. S., & Horrobin, D. F.
Venue
Neuroreport
Published
2002-01
Volume
13
Issue
1
Pages
123-126
ISSN
0959-4965 (ISSN-L)
OpenAlex
W1994562732
Cited by
100
References
1
FWCI
2.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. https://app.cochat.ai/papers/10.1097/00001756-200201210-00029
The paper
Puri, B. K., Bydder, G. M., Counsell, S. J., Corridan, B. J., Richardson, A. J., Hajnal, J. V., Appel, C., McKee, H. M., Vaddadi, K. S., & Horrobin, D. F. (2002). MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment. Neuroreport. https://doi.org/10.1097/00001756-200201210-00029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.